Brokers usually take bids until: Zerodha 4:45 PM, Groww 4:50 PM, Angel One and Upstox 5:00 PM (HNI 4:00 PM). Check the exact time with your broker or bank.
Total Issue Size
Fresh Issue + Offer For Sale
Fresh Issue (FI)
Proceeds go to the company
Offer For Sale (OFS)
Proceeds go to the existing investors
Repayment of borrowings
Funds will be used to repay or prepay outstanding borrowings of the company and certain subsidiaries.
Hospital development and expansion
Capital expenditure toward developing a new hospital and expanding existing hospitals under the Park Medicity and Blue Heavens facilities.
Purchase of medical equipment
Capital expenditure to purchase medical equipment for the company and its subsidiaries Blue Heavens and Ratangiri.
General corporate purposes
The balance of the net proceeds is earmarked for general corporate purposes.
(₹ in Crore)
Tap a bar to highlight a metric across periods and show its values.
Park Medi World Limited operates a chain of multi speciality private hospitals under the Park brand, concentrated largely in north India. The group offers more than 30 specialty and super specialty clinical services spanning internal medicine, neurology, urology, gastroenterology, general surgery, orthopaedics and oncology, backed by intensive care and surgical infrastructure that includes several hundred ICU beds and dozens of operating theatres, along with in house oxygen generation at its facilities. Incorporated in 2011, the company has grown to run 14 hospitals with a combined capacity of around 3,000 beds, spread across Haryana (including Ambala, Gurugram, Karnal, Panipat, Sonipat and Faridabad), Delhi, Punjab (Patiala and Mohali) and Rajasthan (Jaipur and Behror). As of September 2025 the group employed over a thousand doctors and consultants along with more than two thousand nursing staff, supported by a wider base of medical and administrative personnel. The business is led by promoters Dr. Ajit Gupta and Dr. Ankit Gupta. Park Medi World has expanded substantially by acquiring underperforming hospital assets and integrating them into its network, which has helped it become one of the larger private hospital groups in north India. Its scale, quality accreditations and wide specialty mix position it to compete with larger national hospital chains as it continues to invest in capacity expansion and new facilities across the region.
The company raised approximately Rs 276 crore from anchor investors through the allotment of 1,70,37,036 equity shares at the cap price of Rs 162. Domestic mutual funds, including Kotak Mahindra AMC, Helios Mutual Fund, ITI Mutual Fund and Taurus Mutual Fund, together accounted for more than half of the anchor allocation, with other participants including Allianz Global Investors, Reliance General Insurance and Abakkus Asset Management.
Source: RHP • Analysis provided for informational purposes
Last Updated: 9 July 2026, 5:30 AM
Leading north Indian hospital network
The company operates one of the larger private multi speciality hospital chains in north India, with around 3,000 beds across Haryana, Delhi, Punjab and Rajasthan.
Broad, accredited specialty mix
More than 30 specialty and super specialty services are offered across its hospitals, many carrying NABH and NABL quality accreditations.
Track record of acquisition led growth
The group has grown by acquiring underperforming hospital assets and turning them profitable within a short period, helping keep its effective cost per bed low.
Experienced clinical and management team
The business is supported by over a thousand doctors and consultants and a management team with more than two decades of healthcare industry experience.
Consistent revenue and profit growth
Revenue and profit have grown over recent fiscal years, helped by rising patient volumes and better capacity utilisation.
Dependence on key medical staff
A large share of patient footfall and revenue depends on a core group of doctors and specialists, and their departure could affect operations.
Healthcare regulatory exposure
The business operates under strict and evolving healthcare regulations, and any non compliance could lead to penalties or disruption.
Geographic concentration in Haryana
A large majority of revenue comes from hospitals located in Haryana, exposing the company to regional demand and regulatory risk.
Park Medi World Limited
No financial information whatsoever published anywhere, within this website, should be considered as an advice to buy or sell securities or invest in IPOs, or as a guide to doing so in any way whatsoever. All matter published here is purely for educational and information purposes only and under no circumstances should be used for making investment decisions.
We are not a SEBI Registered analyst. Readers must consult a qualified financial advisor prior to making any actual investment decisions, based on information published on this website. The information on this website is based on information available as on date coupled with market perceptions.
You agree with the terms and conditions to use this website.
Grey-market disclaimer. GMP shown here is grey-market news only. We do not trade or deal in the grey market or subject-to rates, nor do we recommend trading in the grey market.
Not investment advice. IPO Nex is an information tool, not investment advice. We do not recommend buying or selling any securities. Always do your own research before applying to any IPO.
IPO Nex does not guarantee any listing gain or return. IPO investments are subject to market risks.
All times are IST.
© 2026 IPO Nex by Niota. All rights reserved.
Sizeable contingent liabilities
The company carries contingent liabilities and guarantees that form a meaningful share of its net worth, which could affect its financial position if they crystallise.
High employee attrition
The company has experienced a relatively high staff attrition rate, which could raise hiring and training costs and affect service quality.